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Follow-up in Newborn Hearing Screening – A Systematic Review 
Abstract 
Introduction: The quality and efficiency of newborn hearing screening programs (NHS) rely 
heavily on appropriate follow-up. The Joint Committee on Infant Hearing recommends a follow-
up rate of more than 95% of infants who fail the initial hearing screening. However, a 70% 
benchmark is considered to be more feasible. This high loss to follow-up (LTF) rate acts as a 
threat to the overall success of NHS programs. The objective of the study was to identify and 
examine the reported rates of LTF, attributed reasons for LTF and strategies undertaken to 
reduce LTF. 
Methods: Using a systematic search, articles published between 2005 to December 2015 were 
identified from PubMed/Medline, Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), Educational Resources Information Center (ERIC), Scopus, Ovid, ProQuest, and 
Cochrane Library. To be included in the review, the study should be exploring the loss to follow-
up or drop-out rate in newborn hearing screening programs and be published in an indexed peer-
reviewed journal in the English language. The main outcome measures were overall rate of LTF, 
factors leading to LTF and measures adopted to overcome LTF. 
Results: 53 articles were short-listed for data extraction. Out of these, 27 were single-center 
studies, 19 were multi-center, 3 compared multiple databases, and 4 used survey-based methods. 
Overall LTF rates of 20% in single-centre and 21% in multiple-centre studies were observed. 
Educational disparity and lack of adequate knowledge among parents were associated with LTF. 
The most commonly used strategy to overcome LTF suggested by studies was the use of an 
adequate data management system.  
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Conclusion: This review is a novel attempt to explore the LTF among NHS studies, reasons for 
LTF and strategies to reduce LTF. This review can act as a basis for planning and execution of 
effective NHS programs.  
Keywords: Newborn hearing screening, follow-up, loss to follow-up, reasons, strategies 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Introduction 
According to the estimates provided by the World Health Organization (WHO), approximately 
7.5 million children in the world have a disabling hearing loss. At least 80% of these children 
live in low to middle-income countries [1,2]. In the absence of timely support and intervention, 
these children may experience lifelong difficulties in speech and language as well as 
complications in educational and vocational achievements [3-5]. 
 Universal Newborn Hearing Screening (UNHS) has enabled early identification of 
infants with congenital or early onset hearing loss [6,7]. Multi-stage screening protocols 
incorporate tests such as Oto-Acoustic Emissions (OAE) and Auditory Brainstem Response 
(ABR). The quality and efficacy of the UNHS program rely heavily on overall coverage 
percentage, quality of testing and reporting, and timely referrals for diagnostic tests, 
interventions and follow-up [8]. Follow-up of infants who have failed hearing screening is 
essential in order to reap maximum benefits from the program. Timely follow-up promotes early 
access to comprehensive diagnostic services and management options for the infants detected 
with hearing loss and their families. The Joint Committee on Infant Hearing (JCIH) has 
recommended the 1-3-6 rule for monitoring follow-up [6]. Under this goal, newborn hearing 
screening should be completed before the infant turns one month of age, complete diagnosis of 
hearing loss by three months of age and the child with hearing loss should be enrolled for early 
intervention before six months of age.  
The JCIH recommends a follow-up rate of more than 95% of infants who fail the initial 
hearing screening [9]. Prieve et al [10] have suggested a 70% benchmark to be more feasible. 
However, one of the major challenges of existing programs is the poor follow-up rate in infants 
who have failed the initial UNHS and have been referred for further testing (referred to as ‘lost 
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to follow-up’ or LTF) [11].. The issues related to LTF are present widely across programs, be it 
in the USA which has the most established UNHS programs or in low to middle-income 
countries which have recently commenced screening programs. In the USA, health care 
providers have frequently reported of poor compliance for follow-up testing of infants referred 
from screening [12,13]. Several contributors to LTF at each level have been identified which 
include: limited access to professionals, time constraints, and other co-morbid conditions [14-
18]. Olusanya [19] reported issues related to LTF in low to middle-income countries to be 
commonly the result of logistic constraints, cost issues, poor infrastructure, and lack of 
appropriate patient data management and tracking systems.  
The overall aims of the present systematic review were to identify and examine the 
reported rates of LTF, contributors to successful follow-up, attributed reasons for LTF, and 
strategies undertaken to reduce LTF.  
Method  
The review was carried out based on the guidelines of the Preferred Reporting Items for 
Systematic Review and Meta-analyses statement (PRISMA).   
Eligibility criteria for type of studies and participants  
The published literature was systematically searched based on a search strategy.  The search was 
limited to English-language studies published during 2005 to December 2015. For the purpose of 
the present review, loss to follow-up (LTF) was defined as the percentage of infants that did not 
present for the second stage of newborn hearing screening after receiving a refer result in the 
initial screen. Only those studies reporting primary data based on a newborn hearing screening 
program were included. Studies that provided an overview or a review of more than one program 
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were excluded, as were opinion and commentary pieces. There was no criteria set for the study 
design in order to include a maximum number of studies. Studies carried out both in normal and 
high risk populations were included, as were those using targeted rather than universal screening.  
Literature search 
The literature search was carried out in February 2016. The search was completed using the 
following electronic databases:  PubMed/Medline, Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), Educational Resources Information Center (ERIC), Scopus, Ovid, 
ProQuest, and Cochrane Library. The keywords such as ‘newborn hearing screening’, universal 
newborn hearing screening’, ‘follow-up’, ‘oto-acoustic emission’, ‘auditory brainstem response’ 
were used to develop search strings as per the requirements of the database using Boolean 
operators such as ‘AND’, ‘OR’ ‘NOT’.  The search string of the PubMed database has been 
attached as Appendix A.  
Study selection  
The search was carried out independently by two authors across all the electronic databases. The 
studies obtained were compiled together using a reference management system and the 
duplicates were eliminated. After removal of duplicates, the authors independently screened the 
titles. After title screening, the abstracts were screened by both the authors. Verbal discussion 
was used to solve any difference of judgements at any stage. The full-length text of the 
shortlisted abstracts was obtained for the data extraction procedure.  
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Data extraction and management 
Data extraction was carried out using a specially pre-designed data extraction form. The form 
was developed following consultation among all the authors. The data was extracted on areas 
such as: purpose of the study, location of study, percentage of LTF, reasons for LTF, measures 
taken to resolve the LTF, key findings and future directions.  
Methodological quality of included studies 
A methodological quality appraisal tool was developed based on previous systematic reviews 
and standard guidelines [20,21]. Each single- and multi-centre study was rated for the questions 
on the tool and total percent scores were calculated. Based on the score obtained, each study was 
rated as follows: 0-33.9% as weak, 34-66.9% as moderate and 67-100% as strong. The tool was 
not applied to survey-based studies or multiple databases, being deemed inappropriate for such 
methods. 
Analysis 
Median and Inter-Quartile Range was used to report the LTF rate across studies. SPSS v. 16 was 
used for the purpose of data analysis. 
Results  
A total of 5145 hits were obtained on combining all of the databases of which 3293 duplicates 
were eliminated. The titles of the remaining 1852 articles were screened to exclude 1500 articles 
as they were not relevant to the review objectives. The remaining 352 abstracts were screened 
and 82 articles were included for next step. Full-text articles were retrieved for the 82 shortlisted 
abstracts. At each stage, agreement of >90% was noted between the two reviewers. Based on the 
full-text, 29 articles were eliminated as either there was no mention of LTF, they did not fulfill 
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the criteria, or they were in a language other than English. Finally, 53 articles were included for 
the data extraction process. Of the 53 studies, 27 were single-center studies, 19 were multi-center 
studies, 3 compared multiple databases, and 4 were based on survey-based methods. Based on 
the World Bank list of economies: 25 studies were from high income countries, 18 were from 
upper middle income countries, 8 were from low middle income countries, and 2 were from low 
income countries. Figure 1 shows the schematic representation of the systematic search process 
that was followed and Table 1 displays the study characteristics.  
Among the included studies, the median and interquartile range (IQR) for the percentage 
of LTF for single center studies was 20 % (9 to 37.30%) and 21.99% (11.50 to 41.40%) for 
multi-center studies.  
The methodological quality rating was carried out for single and multiple-centre studies. 
The tool used is shown in Table 2 and the rating for each study appears in Table 3.  
Based on the percent score obtained, the study was classified as weak, moderate or 
strong. In the single-centre studies, 3 were classified as strong, 19 as moderate and the remaining 
5 as weak. In the multiple-centre studies: 6 were classified as moderate, while 2 were classified 
as weak.  
The review compiled the various reasons stated as contributors to LTF as shown in Table 
4. The measures suggested for reducing LTF are shown in Table 5. 
Discussion 
The present systematic review was carried out to estimate the rate of loss to follow-up (LTF) in 
universal newborn hearing screening programs, to compile factors contributing to LTF and to 
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identify strategies that have been undertaken to reduce it. A comparison was made between 
single- and multi-centre follow-up studies.  
 
Overall rate of LTF reported across the studies 
A report presented by Center for Disease Prevention and Control [76] has suggested that nearly 
half of infants screened for hearing loss are LTF and/or have erroneous or incomplete 
documentation. These high LTF rates reduce the efficiency of early hearing detection and 
intervention programs. Sacket et al [77] have provided a rule of thumb that <5% LTF would lead 
to some bias and >20% would challenge the validity of the results. The findings of the present 
review shed light on the overall LTF rates of 20 % in single-centre studies and 21% in multi-
centre studies carried out in the past 10 years.  Accordingly,  the LTF rates obtained in the 
present review are valid for single-centre studies and is slightly higher for multi-centre studies.  
Factors contributing to successful follow-up across included studies  
Single-centre studies 
In single-centre studies, a multidisciplinary dedicated team of health care professionals 
reportedly formed the crux of successfully implemented UNHS and follow-up. This team was 
comprised of audiologists, physicians, nursing staffs, medical record staff, material management 
personnel, and midwives, along with the active support of parents. The health care professionals 
involved with UNHS must be well-educated and knowledgeable about risk factors for hearing 
loss, in addition to the importance and benefits of UNHS and early intervention services. They 
should also display good communication skills in order to explain the results to the parents of 
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newborns [24,26,31,34,38]. A systematic training of these professionals forms an important 
component of follow-up in UNHS programs [24].  
The other factors reported to contribute to optimal follow-up rates included increased 
public and parental awareness and education [26,35,38]; a focus on risk factors, behavioral signs 
of hearing loss and normal language development [30]; regular and periodic awareness 
campaigns regarding the UNHS program [38];  and use of ABR following TEOAE testing to 
reduce overall expenses [23].  
Multi-centre studies 
The success of a multiple-centre studies was majorly attributed to increasing public awareness 
about the NHS program and its importance [57,59,65,67]. Reducing the distance of follow-up 
facility [52,55], stringent tracking system [59,63] and multi-disciplinary team [52,57] were the 
other important components of multiple center NHS programs. Farid et al [57] suggested that the 
team should optimally be comprised of an obstetrician, pediatrician and audiologist. Additional 
reported factors that contributed to successful follow-up related to family support, telemedicine 
services [65]; insurance types, early initiation of follow-up before 3 months of age [55]; maternal 
education, high family income [52]; emotional and economic support [63] and improved health-
care facilities [59]. 
In database and survey-based studies 
In studies based on compilation of databases, two reasons were predominantly attributed to better 
follow-up rates. These included the importance of documentation of follow-up [69,70]; and 
motivation and commitment from the involved professionals [68,70]. This draws attention to the 
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need to have accurate documentation of follow-up and a dedicated team for a successfully 
implemented NHS program.  
 Four studies used survey methods to compile data on follow-up rates in NHS.  The 
different methods used included: telephonic interview of parents [71], web-based survey tool 
[72], and interviews of centers following NHS through telephone [73] or post [74]. A close co-
operation between parents, midwives, pediatricians, ENT doctors, as well as the cost carriers 
such as insurance companies and Government aid played a vital role in enhancing follow-up 
rates [74]. The other reported contributing factors included maintaining a comprehensive 
demographic database [72] and legislation mandating UNHS [71].  
Factors contributing to LTF  
It is important to identify the factors that contribute to LTF in UNHS. This can help to 
form new regulations, bring improvement and changes in the existing health policies which in 
turn can lead to an effective UNHS program [59]. Twenty-five out of 53 studies discussed the 
factors believed to have influenced the LTF rate. The most commonly reported factor was 
educational disparity or lack of adequate knowledge among parents which was reported by nine 
(36%) studies. Studies have indicated that this inadequate knowledge leads to default in uptake 
of other early intervention services as well [13,14]. The next factor was distance, reported by 
seven (28%) studies. Five studies (20%) reported difficulties due to work constraints and 
unfavorable attitude of parents as being significant factors (Table 4).  
Measures adopted to overcome LTF  
The review also compiled the measures undertaken to increase follow-up in UNHS programs 
which were discussed in 22 out of 53 studies (Table 5). The most commonly reported strategy 
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was the use of an adequate data management system [5 out of 22 studies (23%)], such as 
HiTrack NCHAM database management system or other electronic databases. Data management 
and tracking systems also offer useful storage of patient data which can be used to test the 
efficacy of the screening program [6,53]. Four studies (18%) suggested the need for increasing 
parental education as a major measure. Specifically, providing written screening results to 
parents [4], increasing communication between the parents and medical professionals [5], and 
distributing educational materials to increase knowledge were recommended [33]. 
Limitations and future directions 
The present systematic review was limited only to studies published in the English language and 
in the last 10 years and the results showed that the majority of papers concerned high income 
countries. It also did not include non-published literature such as dissertations and theses as well 
as studies from non-indexed journals that might exist on this subject. It was difficult to estimate 
the overall LTF for studies on multiple databases and surveys, as a wide percentage range was 
reported. This review points out the need to have higher quality studies with well-defined 
inclusion-exclusion criteria, strong methodological bases and experimental/quasi-experimental 
study designs. There is also a certain need to have exact and standard definitions of common 
terminologies and protocols associated with UNHS programs across the different countries. This 
will enable improved generalizability of the study findings. 
 Conclusion  
The present systematic review has been a novel attempt at exploring the LTF rates for UNHS 
programs. The included studies were either single-centre, multi-centre, survey or database 
studies. The overall LTF rate of 20% in single centre studies and 21% in multi-centre studies was 
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noted. The most commonly used or suggested measures leading to increased follow-up across the 
studies included the need of a multidisciplinary dedicated team, a focus on public awareness, and 
the need for better documentation and database systems. This review also helped to identify 
several factors attributed to LTF, the most common being lack of knowledge and larger 
commuter distances. The results obtained from the present review may assist in planning and 
implementation of improved UNHS programs.  
Table 1 Characteristics of studies included in the systematic review 
 Study ID Place, Country  Study design Income 
Group* 
% of loss to follow-up  
 SINGLE CENTRE/HOSPITAL 
1 Khairi  et al22  Malaysia Prospective UMI 29.03 
2 Lin  et al23  Taipei, Taiwan - HI 24.74 
3 Abdullah  et al24  Malaysia - UMI 26.70 
4 Korres  et al25  Greece - HI 58.20 
5 Mukari  et al26  Malaysia - UMI 40.65 
6 Mathur & Dhawan27                       New Delhi, India - LMI 20.00  
7 Swanepoel  et al28  South Africa Retrospective  UMI 68.00 
8 Baflar & Guven29  Turkey - UMI 81.25 
9 Benito-Orejas  et al30  Spain - HI 3.60 
10 Khaimook  et al31  Thailand Prospective  UMI 0.64 
11 Korres  et al32  Greece - HI 65.50 
12 Olusanya  et al33  Lagos, Nigeria Cross-sectional LMI 12.84 
13 Ohl  et al34 France - HI 19.70 
14 Olusanya35 Nigeria Cross-sectional LMI 10.20 
15 Geal Dor et al36  Jerusalem, Israel - HI 17.73 
16 Guastini  et al37  Italy - HI 9.80 
17 Ahmad  et al38  Malaysia Retrospective UMI 37.30 
18 Coenraad  et al39  Netherlands Retrospective HI 7.80 
19 Kim  et al40  Korea Retrospective LI 18.00 
20 Paladini  et al41  Italy - HI 0.31 
21 Sennaroglu  et al42  Turkey - HI 6.20 
22 Tungvachirakul  et 
al43  
Thailand Prospective  UMI 23.20 
23 Lim et al44  Seoul, Korea Retrospective LI 20.09 
24 Arslan  et al45  Turkey Prospective HI 0.64 
25 Augustine  et al46  India Descriptive LMI 17.38 
26 Jewel  et al47 Ludhiana, India Prospective LMI 30.00 
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* The classification of income group of countries is based on the World Bank classification of 
economies given in July 2016 75 
Abbreviations used  
HI: High Income 
27 Qi et al48 Beijing, China - UMI 43.13 
 MULTIPLE CENTRE /HOSPITAL 
28 Swanepoel  et al49  South Africa - UMI 60.00 
29 Calevo  et al50  Italy Prospective 
observational  
HI 11.50 
30 Szyffer  et al51  Poland - HI 37.30 
31 Griz  et al52  Brazil - UMI 14.30 
32 Olusanya  et al53  Lagos, Nigeria - LMI 52.60 
33 Olusanya et al54  Lagos, Nigeria Cross-sectional LMI 51.60 
34 Spivak  et al55 New York, USA Retrospective HI 8.70 
35 Fan  et al56 Taiwan - HI 5.70 
36 Farid  et al57 Egypt Matched Case 
control 
LMI 41.40 
37 Paul58  Cochin, India - LMI 6.28 
38 Cavalcanti  et al59 Brazil Cross-sectional UMI 38.80 
39 Friderichs  et al60  South Africa - UMI 21.99 
40 Zhang et al61  Gansu, China - UMI 19.87 
41 Barker et al62  Australia - HI 19.10 
42 Huang  et al63  Taipei, China Cohort HI 5.60 
43 Pisacene  et al64 Italy - HI 25.00 
44 Bush et al65  Kentucky, USA Retrospective HI 19.00 
45 Firoozbakht et al66  Iran Cross-sectional UMI 30.00 
46 Scheepers  et al67  Western Cape 
Province, South 
Africa 
Retrospective  UMI 54.05 
 MULTIPLE DATABASES  
47 Liu  et al68 Massachusetts, 
USA 
Retrospective HI 5.93 
48 Alam et al69  USA Online Survey HI 35.00 
49 Vos  et al70  Belgium  Descriptive & 
Retrospective 
HI 37.79 
 SURVEY BASED 
50 Lieu et al71 USA Telephonic 
Interview 
HI 15-29 
51 Gaffney et al72 Georgia, USA Web-based survey HI >30.00 
52 Meyer et al73  South Africa Survey design UMI 21-69% for 44% 
programs, >70% for 28% 
programs  
53 Metzger et al74  Switzerland  Retrospective 
consecutive cohort 
HI 13.00 
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UMI: Upper middle Income 
LMI: Lower Middle Income 
LI: Low Income 
 
 
Table 2  
Methodological quality appraisal tool  
Q 1 Was the research question/objective clearly stated? 
Q 2 Was the study population clearly specified and defined? 
Q 3 Were the inclusion and exclusion criteria for being in the study pre-specified and applied uniformly 
to all study participants? 
Q4 Was a sample size justification provided? 
Q5 Was loss to follow-up after baseline testing (screening stage 1) 20% or less? 
Q6 Was a pass/refer criteria clearly specified? 
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Table 3  
Methodological quality appraisal scores obtained for each study  
 Study ID Q1 Q2 Q3 Q4 Q5 Q6 % score* 
Single-centre/hospital  
1 Khairi  et al [22]  1 1 1 1 0 1 83.33  
2 Lin  et al [23]  1 1 0 0 0 1 50.00   
3 Abdullah  et al [24]  1 1 0 0 0 0 33.33 
4 Korres  et al [25]  1 1 0 0 0 1 50.00 
5 Mukari  et al [26]  1 1 0 0 0 0 33.33 
6 Mathur & Dhawan [27]                       1 1 0 0 1 1 66.67 
7 Swanepoel  et al [28]  1 1 0 0 0 1 50.00 
8 Baflar & Guven [29]  1 1 0 0 0 0 33.33 
9 Benito-Orejas  et al [30]  1 1 0 0 1 1 66.67 
10 Khaimook  et al [31]  1 1 0 0 1 0 50.00 
11 Korres  et al [32]  1 1 0 0 0 1 50.00 
12 Olusanya  et al [33]  1 1 0 0 1 1 66.67 
13 Ohl  et al [34] 1 1 0 0 1 0 50.00 
14 Olusanya [35] 1 1 0 0 1 0 50.00 
15 Geal Dor et al [36]  1 1 0 0 1 1 66.67 
16 Guastini  et al [37]  1 1 0 0 1 1 66.67 
17 Ahmad  et al [38]  1 1 0 0 0 0 33.33 
18 Coenraad  et al [39]  1 1 1 0 1 1 83.33 
19 Kim  et al [40]  1 1 0 0 1 1 66.67 
20 Paladini  et al [41]  1 1 0 0 1 0 50.00 
21 Sennaroglu  et al [42]  1 1 0 0 1 0 50.00 
22 Tungvachirakul  et al [43]  1 1 0 0 0 0 33.33 
23 Lim et al [44]  1 1 1 0 1 1 83.33 
24 Arslan  et al [45]  1 1 0 0 1 1 66.67 
25 Augustine  et al [46]  1 1 0 0 1 1 66.67 
26 Jewel  et al [47] 1 1 0 0 0 1 50.00 
27 Qi et al [48] 1 1 0 0 0 1 50.00 
Multiple-centres/hospitals  
28 Swanepoel  et al [49]  1 1 0 0 0 1 50.00 
29 Calevo  et al [50]  1 1 0 0 1 1 66.67 
30 Szyffer  et al [51]  1 1 0 0 0 0 33.33 
31 Griz  et al [52]  1 1 0 0 1 1 66.67 
32 Olusanya  et al [53]  1 1 1 0 0 0 50.00 
33 Olusanya et al [54]  1 1 0 0 0 0 33.33 
34 Spivak  et al [55] 1 1 0 0 1 0 50.00 
35 Fan  et al [56] 1 1 0 0 1 0 50.00 
36 Farid  et al [57] 1 1 0 0 0 0 33.33 
37 Paul [58]  1 0 0 0 1 0 33.33 
38 Cavalcanti  et al [59] 1 1 1 0 0 0 50.00 
39 Friderichs  et al [60]  1 1 1 0 0 1 66.67 
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*total score divided by total number of items in the tool multiplied by 100. 
  
40 Zhang et al [61]  1 1 0 0 1 0 50.00 
41 Barker et al [62] 1 0 0 0 1 1 50.00 
42 Huang  et al [63]  1 1 0 0 1 1 66.67 
43 Pisacene  et al [64] 1 1 0 0 0 0 33.33 
44 Bush et al [65]  1 1 1 0 1 0 66.67 
45 Firoozbakht et al [66]  1 1 1 0 0 0 50.00 
46 Scheepers  et al [67]  1 1 0 0 0 1 50.00 
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Table 4 
Contributing factors leading to LTF 
Sr. 
no  
Factors for Loss to follow-up 
1 Educational disparities and lack of knowledge among parents [24,25,28,34,35,52,65,67,74] 
2 Distance [26,30,33,48,52,54,62] 
3 Work constraints [24,26,33,35,54] 
4 Unfavorable attitudes [25,49,62,67,73]  
5 Less priority given to hearing compared to other medical conditions by parents [40,62,71,73] 
6 Rescreened at some other center [34,40,48] 
7 Inaccurate contact details [35,54,72] 
8 Change of Address [33,54,68] 
9 Superstitious and cultural beliefs [24, 49,54] 
10 Barriers to adequate healthcare [65,71,74] 
11 Financial constraints [28, 52,  65] 
12 Lack of health insurance [55,65,67] 
13 Forgot to keep an appointment [26, 33, 67]  
14 Lack of scheduling a follow-up appointment  [25, 26, 62] 
15 Lack of understanding of results [30, 50] 
16 Parental refusal [26, 68] 
17 Lack of service provider’s knowledge [62, 74] 
18 Overburdened nursing staff used as a screener [60] 
19 Lack of family support [54] 
20 Lack of service system capacity [74] 
21 Communication failure, socio-economic barriers, lack of parental reminders [71] 
22 Incomplete test reports [69] 
23 Short time to implement NHS [49] 
24 Early discharge [34] 
25 Screening staff on leave [24] 
26 Reduced maternal education [52] 
27 Anxiety [73] 
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Table 5 
Measures suggested to reduce LTF 
Sr. 
No  
Measures to increase follow-up  
1 Database management system [28, 38, 60, 63, 64] 
2 Increased parental education [25, 26, 40, 54] 
3 Telephone reminders [24, 35, 46, 60] 
4 Multidisciplinary team [33, 50, 71] 
5 Flexibility in scheduling appointments [26, 48] 
6 Visual reminders and written reports [60, 71] 
7 Financial support [63, 64] 
8 Handouts to parents [24, 71] 
9 Psychological support [50, 63] 
10 Counselling [25, 46] 
11 Centralized screening facility [58] 
12 Scheduling at the time of immunization [47] 
13 Minimizing repeat visits [54] 
14 Verbal reminders [23] 
15 Text message/letters/reminders (single or in combination) [73] 
16 Reminders by community health care workers through home visits 
[60] 
17 Knowledge of local language and culture by screening personnel [60] 
18 Collaboration of state programs [68] 
19 Increasing knowledge of medical staff [40] 
20 Hearing screening reports sent to primary care physicians [71] 
21 Free screening and follow-up testing [33] 
22 Increasing knowledge of prospective mothers that hearing screening is 
of no harm [33] 
23 Scheduling follow-up testing at one week rather than six weeks [46] 
24 Common birthing package in private hospitals [28] 
25 Maintaining  first screening book  [38] 
26 Communicating hearing test results [25] 
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Figure 1 
PRISMA chart explaining the process followed in this systematic review 
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Appendix- A 
Search string for PubMed 
(((((((((newborn) OR infant*) OR neonate*) OR pediatric) OR paediatric) OR child*)) AND 
(((((((((hearing screening) OR audiological screening) OR ABR) OR auditory brainstem 
response*) OR BERA) OR brainstem evoked response audiometry) OR AABR) OR 
automated auditory brainstem evoked response*) OR automated auditory brainstem 
evoked potential*)) AND ((((follow-up) OR follow-up rate) OR rate of follow-up) OR 
loss to follow-up)) NOT heart  
 
Filters used: published in the last 10 years, Humans, English, Infant: birth-23 months. 
 
 
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
References 
[1] B.O. Olusanya, K.J. Neumann, J.E.Saunders, The global burden of disabling hearing 
impairment: a call to action, Bull World Health Organ. 92 (2014) 367-373. 
[2] G. Stevens, S.Flaxman, E. Brunskill E, C.D. Mathers, M. Finucane, Global and regional 
hearing impairment prevalence: an analysis of 42 studies in 29 countries, Eur J Pub 
Health. 23 (2013) 146-152. 
[3] W.H. Mc Kellin, Hearing Impaired families: The social ecology of hearing loss, Soc. Sci 
Med. 40(1995) 1469–1480. 
[4] S. Niemann, D. Greenstein, D. David, Helping children who are deaf: Family and 
community support for children who are do not hear well. Adapt Phys Activ Q. 21 (2004) 
416-418. 
[5] B.O. Olusanya, O.B. Eletu, O. Odusote, A.O. Somefun, O.Olude, Early detection of 
infant hearing loss: Current experiences of health professionals in a developing country. 
Acta Paediatr. 95 (2006) 1300- 1302. 
[6] Joint Committee of Infant Hearing (JCIH) Year 2007 position statement: Principles and 
guidelines for early hearing detection and intervention programs, Pediatr. 120 (2007) 
898-921.  
[7] D.C. Thompson, H.McPhillips, R.L. Davis, T.A. Lieu, C.J.Homer, M. Helfand, Universal 
Newborn Hearing Screening: Summary of evidence, JAMA. 286 (2001) 2000-2010. 
[8] G. Loeber, D.Webster, A. Aznarez, Quality evaluation of newborn screening programs, 
Acta Paediatr Suppl. 88 (1999) 3-6. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
[9] Joint Committee on Infant Hearing (JCIH) Year 2000 Position Statement: Principles and 
guidelines for early hearing detection and intervention programs, Pediatr. 106 (2000) 798 
–817. 
[10] B. Prieve, L.Dalzell, A. Berg, M. Bradley, A. Cacace, D.Campbell, et al., The New York 
State universal newborn hearing screening demonstration project: outpatient outcome 
measures, Ear Hear.21(2000) 104-117. 
[11] M.E. Meyer, D.W. Swanepoel, Newborn hearing screening in the private health care 
sector – a national survey, S Afr Med J. 101 (2011) 665- 6667. 
[12] S.A. Russ, D. Hanna, J. DesGeorges, I. Forsman, Improving follow-up to newborn 
hearing screening: a learning-collaborative experience, Pediatr. 126 (2010) S59-69. 
[13] S. Shulman, M. Besculides, A. Saltzman, H. Ireys, K.R.White,I. Forsman. Evaluation of 
the universal newborn hearing screening and intervention program, Pediatr. 126 (2010) 
S19-27. 
[14] J. Coplan, Deafness: Ever Heard of It? Delayed Recognition of permanent Hearing Loss,  
Pediatr. 79 (1987) 206- 213. 
[15] M. Harrison, J. Roush, Age of suspicion, identification, and intervention for infants and 
young children with hearing loss: a national study. Ear  Hear.17(1996) 55-62. 
[16] M.P. Moeller, L.Eiten, K.R.White, L. Shisler, Strategies for educating physicians about 
newborn hearing screening, J  Acad of rehabil audiol. 39 (2006) 11-32. 
[17] M.P. Moeller, K.R.White, L. Shisler, Primary care physicians' knowledge, attitudes, and 
practices related to newborn hearing screening, Pediatr. 118 (2006)1357-1370. 
[18] S.J Norton, M.P. Gorga, J.E.Widen, R.C. Folsom, Y. Sininger, B. Cone-Wesson, et al., 
Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
emission, distortion product otoacoustic emission, and auditory brain stem response test 
performance, Ear Hear. 21 (2000) 508-528. 
[19] B.O. Olusanya, Screening for neonatal deafness in resource-poor countries: challenges 
and solutions, Res Rep Neonatol. 5 (2015) 51– 64. 
[20] E.L. Davids, N.V. Roman, A systematic review of the relationship between parenting 
styles and children’s physical activity, Afr J Phys Health Educ, Recr  Dance. 2 (2014) 
228-246. 
[21] Quality Assessment Tool for Observational Cohort and Cross Sectional Studies. NIH. 
2014. Available from http://www.nhlbi.nih.gov/health-pro/guidelines/in-
develop/cardiovascular-risk-reduction/tools/cohort  (Accessed 20th May 2016). 
[22] M.D. Khairi, S. Din, H. Shahid, A.R. Normastura, Hearing screening of infants in 
Neonatal Unit, Hospital Universiti Sains Malaysia using transient evoked otoacoustic 
emissions, J Laryngol  Otol. 119 (2005) 678–683. 
[23] H.C. Lin, M.T. Shu, K.S. Lee, G.M. Ho, T.Y. Fu, S. Bruna, et al., Comparison of hearing 
screening programs between one step with transient evoked otoacoustic emissions 
(TEOAE) and two steps with TEOAE and automated auditory brainstem response, 
Laryngoscope. 115 (2005)1957-1962. 
[24] A. Abdullah, M.Y. Hazim, A. Almyzan, A.G. Jamilah, S.Roslin, M.T. Ann, et al., 
Newborn hearing screening: experience in a Malaysian hospital, Singapore Med J. 47 
(2006) 60-64. 
[25] S.G. Korres, D.G. Balatsouras, E. Gkoritsa, P. Eliopoulos, E. Rallis, E. Ferekidis, Success 
rate of newborn and follow-up screening of hearing using otoacoustic emissions, Int J 
Pediatr Otorhinolaryngol.70 (2006)1039-1043. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
[26] S.Z. Mukari, K.Y. Tan, A. Abdullah, A pilot project on hospital-based universal newborn 
hearing screening: lessons learned, Int J Pediatr Otorhinolaryngol.70 (2006) 843-851. 
[27] N.N. Mathur, R. Dhawan, An alternative strategy for universal infant hearing screening 
in tertiary hospitals with a high delivery rate, within a developing country, using transient 
evoked oto-acoustic emissions and brainstem evoked response audiometry, J Laryngol 
Otol. 121 (2007) 639-643. 
[28] D.W. Swanepoel, S. Ebrahim, A. Joseph, P.L. Friedland, Newborn hearing screening in a 
South African private health care hospital, Int J Pediatr Otorhinolaryngol. 71 (2007) 881-
887. 
[29] F. Baflar, A.G. Güven, The Distribution of Risk Factors among High Risk Infants who 
Failed at Hearing Screening, Mediterr J Otol (2008) 211- 216. 
[30] J.I. Benito-Orejas, B. Ramirez, D. Morais, A. Almaraz, J.L. Fernandez-Calvo, 
Comparison of two-step transient evoked otoacoustic emissions (TEOAE) and automated 
auditory brainstem response (AABR) for universal newborn hearing screening programs, 
Int J Pediatr Otorhinolaryngol. 72 (2008)1193-1201. 
[31] W. Khaimook, S. Chayarpham, S. Dissaneevate, The high-risk neonatal hearing 
screening program in Songklanagarind Hospital, J Med Assoc Thai. 91 (2008)1038-1042. 
[32] S. Korres, T.P. Nikolopoulos, E.E. Peraki, M. Tsiakou, M. Karakitsou, N. 
Apostolopoulos, et al., Outcomes and efficacy of newborn hearing screening: strengths 
and weaknesses (success or failure?), Laryngoscope.118 (2008)1253-1256. 
[33] B.O. Olusanya, S.L. Wirz, L.M. Luxon, Hospital based universal newborn hearing 
screening for early detection of permanent congenital hearing loss, Int J Pediatr 
Otorhinolaryngol. 72 (2008) 991-1001.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
[34] C. Ohl, L. Dornier, C. Czajka, J.C. Chobaut, L. Tavernier, Newborn hearing screening on 
infants at risk, Int J Pediatr Otorhinolaryngol. 73 (2009) 1691-1695. 
[35] B.O. Olusanya. Follow-up default in a hospital-based universal newborn hearing 
screening programme in a low-income country, Child Care Health Dev. 35 (2009)190-
198. 
[36] M. Geal-Dor, C. Adelman, H. Levi, G. Zentner, C.Stein-Zamir. Comparison of two 
hearing screening programs in the same population: oto-acoustic emissions (OAE) 
screening in newborns and behavioral screening when infants, Int J Pediatr 
Otorhinolaryngol. 12 (2010) 1351-1355. 
[37] L. Guastini, R. Mora, M. Dellepiane, V.Santomauro, M. Mora, A. Rocca, et al., 
Evaluation of an automated auditory brainstem response in a multi-stage infant hearing 
screening, Eur Arch Otorhinolaryngol. 267 (2010)1199-1205. 
[38] A. Ahmad, I. Mohamad, S. Mansor, M.K. Daud, D. Sidek, Outcome of a newborn 
hearing screening program in a tertiary hospital in Malaysia: the first five years, Ann 
Saudi Med. 31 (2011) 24-28. 
[39] S. Coenraad, A. Goedegebure, L.J. Hoeve, An initial overestimation of sensorineural 
hearing loss in NICU infants after failure on neonatal hearing screening, Int J Pediatr 
Otorhinolaryngol. 75 (2011)159-162. 
[40] J.H. Kim, K.B. Lee, Y.C. Koo, S.A. Hong, Y. Lee, E.J. Son, Evaluation of Transient 
Evoked Otoacoustic Emission in the Newborn Hearing Screening Program in Neonatal 
Intensive Care Unit, Korean J Audiol 15 (2011) 81-84. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
[41] A. Paladini, C. Farneti, M. Manzoli, M. Limarzi, R. Bigazzi, M. Farneti, Newborn 
Hearing Screening: The experience of Ausl of Cesna, Acta Med  Mediterr.25(2009)111-
116. 
[42] Sennaroglu G, Akmese PP. Risk Factors for Hearing Loss and Results of Newborn 
Hearing Screening in Rural Area, J Int Adv Otol. 7 (2011)343-350. 
[43] V. Tungvachirakul, S. Boonmee, T. Nualmoosik, J. Kamjohnjiraphun, W. Siripala,  
W.Sanghirun, et al., Newborn Hearing Screening at Rajavithi Hospital, Thailand: 
Hearing Loss in Infants Not Admitting in Intensive Care Unit, J Med Assoc Thai. 94 
(2011)108-112. 
[44] H.W. Lim, E.A. Kim, J.W. Chung, Audiological Follow-up Results after Newborn 
Hearing Screening Program, Clin Exp Otorhinolaryngol. 5 (2012)57-61. 
[45] S. Arslan, A.U. Işik, M. Imamoğlu, M. Topbaş, Y. Aslan, A. Ural, Universal newborn 
hearing screening; automated transient evoked otoacoustic emissions, B-ENT. 9 (2013) 
122- 131. 
[46] A.M. Augustine, A.K. Jana, K.A. Kuruvilla, S. Danda, A. Lepcha, J. Ebenezer, et al., 
Neonatal Hearing Screening – Experience from a Tertiary Care Hospital in Southern 
India. Indian Pediatr. 51 (2014)179-183. 
[47] J. Jewel, P.V.Varghese, T. Singh, A. Varghese. Newborn Hearing Screening—
Experience at a Tertiary Hospital in Northwest India, Int J Otolaryngol Head Neck Surg. 
02 (2013) 211-214. 
[48] B. Qi, X. Cheng, H. En, B. Liu, S. Peng, Y. Zhen, et al., Assessment of the feasibility and 
coverage of a modified universal hearing screening protocol for use with newborn babies 
of migrant workers in Beijing, BMC Pediatr. 13 (2013) 116. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
[49] D.W. Swanepoel, R. Hugo, B. Louw, Infant hearing screening at immunization clinics in 
South Africa, Int J Pediatr Otorhinolaryngol. 70 (2006)1241-1249. 
[50] M.G. Calevo, P. Mezzano, E. Zullino, P. Padovani, F. Scopesi, G. Serra, et al., Neonatal 
hearing screening model: an Italian regional experience, J Matern Fetal  Neonatal Med. 
20 (2007) 441-448. 
[51] W. Szyfter, M. Wrobel, M. Radziszewska-Konopka, J. Szyfter-Harris, M. Karlik. Polish 
universal neonatal hearing screening program-4-year experience (2003-2006), Int J 
Pediatr Otorhinolaryngol.72(2008)1783-1787. 
[52] S. Griz, G. Merces, D. Menezes, M.L.Lima, Newborn hearing screening: an outpatient 
model. Int J Pediatr Otorhinolaryngol. 73 (2009) 1-7. 
[53] B.O. Olusanya, O.M. Ebuehi, A.O. Somefun. Universal infant hearing screening 
programme in a community with predominant non-hospital births: a three-year 
experience. J epidemiol Community Health. 63 (2009) 481-487. 
[54]       B.O. Olusanya, S.L. Wirz, , L.M. Luxon, Community-based infant hearing screening for 
early detection of permanent hearing loss in Lagos, Nigeria: a cross-sectional study, Bull  
World Health Organ. 86 (2009) 956-963. 
[55] L. Spivak, H. Sokol, C. Auerbach, S. Gershkovich. Newborn Hearing Screening Follow-
Up: Factors Affecting Hearing Aid Fitting by 6 Months of Age. Am J Audiol. 18 (2009) 
24-33. 
[56] J.Y. Fan, L.S. Chen, J.C. Lai, M.K. Chen, H.C. Chen. A prepaid newborn hearing 
screening programme: a community based study. B-ENT. 6 (2010) 265-269. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
[57] A.S Farid, I.S. Seoud, T.M. Dessouky, M.M. Shabrawy, Z.M. Mounir, Newborn hearing 
screening: importance and characteristics of a high-risk register in a neonatal intensive 
care unit,  Egypt J Otolaryngol. 28 (2012) 17–21. 
[58] A.K. Paul, Early identification of hearing loss and centralized new-born hearing 
screening facility-The Cochin experience. Indian Pediatr. 48 (2011) 355-359. 
[59] H.G. Cavalcanti, R.O. Guerra, The role of maternal socioeconomic factors in the 
commitment to universal newborn hearing screening in the Northeastern region of Brazil, 
Int J Pediatr Otorhinolaryngol.  76 (2012) 1661-1667. 
[60] N. Friderichs, D.W. Swanepoel, J.W. Hall 3rd., Efficacy of a community-based infant 
hearing screening program utilizing existing clinic personnel in Western Cape, South 
Africa, Int J Pediatr Otorhinolaryngol. 76 (2012) 552-559. 
[61] Z. Zhang, W. Ding, X. Liu, B. Xu, W. Du, S. Nan, et. al., Auditory screening concurrent 
deafness predisposing genes screening in 10,043 neonates in Gansu province, China, Int J 
Pediatr Otorhinolaryngol.76 ( 2012) 984-988. 
[62] M.J. Barker, E.K. Hughes, M.Wake, NICU-only versus universal screening for newborn 
hearing loss: Population audit, J Paediatr Child Health. 49 (2013) E74-79. 
[63] H.M. Huang, S.H. Chiang, Y.S. Shiau, W.Y. Yeh, H.C. Ho, L. Wang, et al., The 
universal newborn hearing screening program of Taipei City, Int J Pediatr 
Otorhinolaryngol. 77 (2013) 1734-1737. 
[64] A. Pisacane, G. Auletta, F. Toscano, M. Errichiello, F. Barrier, P. Riccardi, et al., 
Feasibility and effectiveness of a population-based newborn hearing screening in an 
economically deprived region of Italy, Int J Pediatr Otorhinolaryngol.77(2013) 329-333. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
[65] M.L. Bush, K. Bianchi, C. Lester, J.B. Shinn,T.J. Gal, D.W. Fardo, et al., Delays in 
diagnosis of congenital hearing loss in rural children, J Pediatr. 164 (2014) 393-397. 
[66] M. Firoozbakht, S. Mahmoudian, F. Alaeddini, M. Esmaeilzadeh, M. Rafiei, A. 
Firouzbakht, et. al., Community-based newborn hearing screening programme for early 
detection of permanent hearing loss in Iran: an eight-year cross-sectional study from 2005 
to 2012, J  Med Screen. 21 (2014)10- 17. 
[67] L.J. Scheepers, D.W. Swanepoel, T. Roux, Why parents refuse newborn hearing 
screening and default on follow-up rescreening--a South African perspective, Int J Pediatr 
Otorhinolaryngol. 78 (2014) 652-658. 
[68] C.L. Liu, J. Farrell, J.R. MacNeil, S. Stone, W. Barfield, Evaluating loss to follow-up in 
newborn hearing screening in Massachusetts, Pediatr. 121 (2008) 335- 343. 
[69] S. Alam, M. Gaffney, J. Eichwald, Improved newborn hearing screening follow-up 
results in more infants identified, J Public Health Manag Pract. 20 (2014) 220-223. 
[70] B. Vos, R. Lagasse, A. Leveque, Main outcomes of a newborn hearing screening 
program in Belgium over six years, Int J Pediatr Otorhinolaryngol. 78 (2014)1496-1502. 
[71] J.E Lieu, R.K. Karzon, C.C. Mange, Hearing Screening in the Neonatal Intensive Care 
Unit: Follow-Up of Referrals, Am J Audiol. 15 (2006) 66-74. 
[72] M. Gaffney, D.R. Green, C. Gaffney, Newborn Hearing Screening and Follow-up: Are 
Children Receiving Recommended Services? Public Health Rep. 125 (2010)199-207. 
[73] M.E Meyer, D.W. Swanepoel, T. Roux, M. Linde, Early detection of infant hearing loss 
in the private health care sector of South Africa, Int J Pediatr Otorhinolaryngol. 76 (2012) 
698-703. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
[74] D. Metzger, T.F. Pezier, D. Veraguth, Evaluation of universal newborn hearing screening 
in Switzerland 2012 and follow-up data for Zurich, Swiss Med Wkly. 143 (2013)w13905. 
[75] World bank list of economies. 2016. Avaiable from: 
https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-
and-lending-groups  (Accessed on 23rd August 2016). 
[76] Center for Disease Control and Prevention. Summary of 2007 national EHDI data. 2007; 
Available from: http://www.cdc.gov/ncbddd/hearingloss/ehdi-data2007.html (Accessed 
on 20th May 2016) 
[77] D.L. Sackett, S.E. Strauss, W.S. Richardson, W. Rosenberg, R.B. Haynes, Evidence-
based medicine: how to practice and teach EBM. Edinburgh: Churchill Livingstone, 
2000. 
 
 
